Table 3.
Acute toxicity in organ and hematological parameters of female mice treated with 2 and 5 g of kg−1 EBSp orally.
Parameters | Control | 2 g.kg−1 | 5 g.kg−1 |
---|---|---|---|
Body mass (%) | 100.5 ± 0.5a | 100.3 ± 0.4a | 102.7 ± 1.0a |
Liver (g.100 g−1 BW) | 4.03 ± 0.07a | 5.07 ± 0.25b | 4.96 ± 0.18b |
Kidney (g.100 g−1 BW) | 1.12 ± 0.04a | 1.11 ± 0.06a | 1.12 ± 0.03a |
Spleen (g.100 g−1 BW) | 0.31 ± 0.02a | 0.32 ± 0.02a | 0.30 ± 0.02a |
Heart (g.100 g−1 BW) | 0.50 ± 0.02a | 0.51 ± 0.01a | 0.53 ± 0.01a |
Lung (g.100 g−1 BW) | 0.66 ± 0.02a | 0.72 ± 0.02a | 0.74 ± 0.07a |
CNS (g.100 g−1 BW) | 1.79 ± 0.05a | 1.92 ± 0.05a | 1.72 ± 0.07a |
Erythrocytes (106.μL−1) | 10.26 ± 0.40a | 9.68 ± 0.09a | 9.44 ± 0.11a |
Hemoglobin (g.dL−1) | 14.22 ± 0.47a | 13.82 ± 0.15a | 13.40 ± 0.23a |
Hematocrit (%) | 56.46 ± 2.51a | 53.86 ± 0.61a | 51.54 ± 0.59a |
MCV (fL) | 54.98 ± 0.51a | 55.62 ± 0.42a | 54.60 ± 0.31a |
MCH (pg) | 13.86 ± 0.12a | 14.26 ± 0.11a | 14.18 ± 0.13a |
MCHC (%) | 25.22 ± 0.30a | 25.68 ± 0.05a | 26.00 ± 0.16a |
RDW-SD (fL) | 26.48 ± 0.57a | 26.12 ± 0.16a | 25.84 ± 0.40a |
RDW-CV (%) | 19.82 ± 0.40a | 18.72 ± 0.12a | 18.70 ± 0.07a |
Platelet (103.μL−1) | 919.00 ± 244.00a | 706.20 ± 34.86b | 661.00 ± 31.26b |
Leucocytes (103.μL−1) | 2.06 ± 0.25a | 4.83 ± 0.41b | 5.07 ± 0.23b |
Neutrophil (%) | 0.09 ± 0.03a | 0.11 ± 0.01a | 0.08 ± 0.02a |
Lymphocyte (%) | 1.98 ± 0.24a | 4.71 ± 0.40b | 4.97 ± 0.24b |
Monocyte (%) | 0.02 ± 0.01a | 0.01 ± 0.00a | 0.01 ± 0.00a |
Eosinophil (%) | 0.00 ± 0.00a | 0.00 ± 0.00a | 0.00 ± 0.00a |
Basophil (%) | 0.01 ± 0.00a | 0.00 ± 0.00a | 0.00 ± 0.00a |
BW: body weight; CNS: the central nervous system; MCV: mean corpuscular volume; MCH: mean corpuscular hemoglobin; MCHC: mean corpuscular hemoglobin concentration; RDW-SD: red cell distribution width-standard deviation; RDW-CV: red cell distribution width-coefficient of variation. The data are presented as the mean ± standard error of the mean. Different letters indicate significant differences between the groups, with P < 0.05.